[Indications for respiratory complications during the use of oral nifedipine as a tocolytic agent, especially in patients with multiple pregnancies].
Oei
S G
SG
Van de Water
M
M
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D004417:Dyspnea / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008168:Lung / Q000187:drug effects / Q000196:embryology* / Q000502:physiology; D009543:Nifedipine / Q000009:adverse effects* / Q000627:therapeutic use; D007752:Obstetric Labor, Premature / Q000188:drug therapy / Q000517:prevention & control*; D011247:Pregnancy; D011256:Pregnancy Outcome; D011272:Pregnancy, Multiple; D015145:Tocolysis / Q000379:methods*; D015149:Tocolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D015149:Tocolytic Agents; D009543:Nifedipine